Pear VC Backs Greatly Health in $4 Million Seed Round for Supportive Oncology Care

According to a recent LinkedIn post from Pear VC, the venture firm is highlighting its participation in a $4 million seed round for Greatly Health. The post describes Greatly Health as developing an integrated model of cancer care that combines exercise, nutrition, and mind‑body interventions into the treatment pathway.

The LinkedIn post points to clinical validation of Greatly Health’s model at Memorial Sloan Kettering, citing reported outcomes such as a 16% improvement in two‑year overall survival, a 69% reduction in hospitalizations, and 42% fewer treatment disruptions. A quoted Pear partner characterizes the approach as already proven in terms of survival, acute care utilization, and medication adherence, with the company now aiming to scale access via technology and industry partnerships.

For investors, the post suggests Pear VC is increasing its exposure to value‑based, outcomes‑driven healthcare solutions in oncology, a segment that could benefit from payor and provider interest in reducing hospitalizations and improving adherence. If Greatly Health’s reported results can be replicated at scale, Pear’s stake could provide upside through potential reimbursement alignment, strategic partnerships with health systems, and eventual exit opportunities in the digital health or oncology services ecosystem.

The involvement of co‑investors Commonweal Ventures and Flare Capital Partners also signals broader early‑stage capital interest in this niche of supportive oncology care. While the seed round size is modest, the focus on clinically validated results and enterprise partnerships may position Greatly Health for follow‑on financings, which could incrementally enhance Pear VC’s portfolio diversification and visibility in the health‑tech sector.